BSC Fights Bid To Block Thrombosis Info At Stent Trial
Boston Scientific Corp. is asking a court to reconsider its decision to preclude certain references to the increased risk of thrombosis posed by rival medical device maker Cordis Corp.'s Cypher heart...To view the full article, register now.
Already a subscriber? Click here to view full article